Fractionated illumination for oesophageal ALA-PDT: Effect on blood flow and PpIX formation

Lasers in Medical Science

Volumn 16, Issue 1, 2001, Pages 16-25

  Van den Boogert, J ^a   Van Staveren, H J ^a   De Bruin, R W F ^a   Siersema, P D ^a   Van Hillegersberg, R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ALA; Barrett's oesophagus; Fractionated illumination; PDT; Rat

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARRETT ESOPHAGUS; BLOOD FLOW; CONTROLLED STUDY; DOSIMETRY; ESOPHAGUS; FLUORESCENCE; ILLUMINATION; LASER FLOWMETER; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RAT; VASODILATATION;

EID: 0035140829     PISSN: 02688921     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00011331     Document Type: Article

References (38)

1. The photochemistry, photobiology, and phototherapeutic use of porphyrins
2. Initial results using low-dose photodynamic therapy in treatment of Barrett's esophagus
3. Barrett's esophagus: Photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer
4. Controlled trial of low dose photodynamic therapy for Barrett's esophagus
5. Photodynamic therapy eliminates dysplasia in Barrett's esophagus
6. Can consistent tissue necrosis be achieved during photodynamic therapy for high-grade dysplasia or cancer within Barrett's esophagus?
7. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX
8. Photodynamic therapy for Barrett's oesophagus: A prospective randomised placebo-controlled trial
9. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid
10. Photodynamic inactivation of cancer cells in vitro. Effect of irradiation temperature and close fractionation
11. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: Increased damage after multiple irradiations
12. Effectiveness of δ-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo
13. Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies
14. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC
15. Photodynamic therapy of a transplanted pancreatic cancer model using metatetrahydroxyphenylchlorin (mTHPC)
16. Enhanced effectiveness of photodynamic therapy with laser light fractionation in patients with esophageal cancer
17. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers
18. Effect of photodynamic therapy on blood flow in normal and tumor vessels
19. A comparison of the effect of photodynamic therapy on normal and tumour blood vessels in the rat microcirculation
20. Tumour vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolevulinic acid
21. The effect of aminolaevulinic acid-induced, protoporphyrin IX mediated photodynamic therapy on the cremaster muscle circulation in vivo
22. Photodynamic therapy using intravenous delta-aminolaevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats
23. Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser Doppler perfusion imaging
24. Fractionated treatment of CaD2 tumors in mice sensitized with aluminium phtalocyanine tetrasulfonate
25. Kinetics, localization and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus
26. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin
27. Timing of illumination is essential for effective and safe photodynamic therapy: A study in the normal rat oesophagus
28. Construction, quality assurance and calibration of spherical isotropic fibre optic light diffusers
29. Measurement of hepatic perfusion in rats by laser Doppler flowmetry
30. Photodynamic therapy for esophageal lesions: Selectivity depends on wavelength, power and light dose
31. In-vivo photoproducts formation during PDT with ALA-induced endogenous porphyrins
32. Photoproduct formation during irradiation of tissues containing protoporphyrin
33. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: The effect of light dose and irradiance and the resulting biological effect
34. Enhanced photodynamic effect using fractionated laser light
35. Comparative study between pulsed and continuous wave lasers for Photofrin® photodynamic therapy
36. The effect of ALA and radiation on porphyrin/heme biosynthesis in endothelial cells
37. Fractionated illumination in esophageal PDT: Effect on ferrochelatase activity
38. Induction of immune infiltration into murine SCCVII tumour by Photofrin-based photodynamic therapy